The DEEP project has received research funding from the European Union under the 7th Framework Programme

DEEP - “Towards new frontiers of paediatric clinical research”

DEEP – “Towards new frontiers of paediatric clinical research”

Febbraio 27, 2015
Comments off

Even the “Corriere Sociale,” the section of the Corriere della Sera dedicated to issues of volunteering and Third Sector, has published on February 27, 2015, an article on the commitment of CVBF and its activities in the field of rare diseases and paediatrics. The article emphasizes how the DEEP project significantly contributes to the paediatric research, by aiming to ensure to many children around the world the availability of a new formulation of deferiprone (DFP): the first oral iron chelator developed in Europe,  specifically tested for them. In particular, DEEP will make deferiprone  available as first-line treatment in children of any age, affected by β-thalassaemia major and other transfusion dependent haemoglobinopathies, the more frequent anaemia in the world (especially in the Mediterranean).